Therefore, we considered that no statistical significance of relationship between counts of MVD assessed by other biomarkers including CD31, CD34 and CD105, and prognosis of cervical cancer patients was limited by a few number of related studies. This evidence concerns the gene PECAM1 and cervical carcinoma.